Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cell adhesion molecules 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Cell adhesion molecules
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬1. Cell adhesion molecules
|
||||||||||||||||||||||||||||||||||||
| 2 | Cell adhesion molecules 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Efalizumab Efalizumab 💬Cell adhesion molecules
| Efalizumab | 011 [9] 11, 13, 37, 46, 53, 61, 95, 96, 221 💬2. Cell adhesion molecules
|
||||||||||||||||||||||||||||||||||||
| 3 | Epstein-Barr virus infection 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Epstein-Barr virus infection
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬3. Epstein-Barr virus infection
|
||||||||||||||||||||||||||||||||||||
| 4 | Epstein-Barr virus infection 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Efalizumab Efalizumab 💬Epstein-Barr virus infection
| Efalizumab | 011 [9] 11, 13, 37, 46, 53, 61, 95, 96, 221 💬4. Epstein-Barr virus infection
|
||||||||||||||||||||||||||||||||||||
| 5 | Human T-cell leukemia virus 1 infection 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Human T-cell leukemia virus 1 infection
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬5. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||
| 6 | Human T-cell leukemia virus 1 infection 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Efalizumab Efalizumab 💬Human T-cell leukemia virus 1 infection
| Efalizumab | 011 [9] 11, 13, 37, 46, 53, 61, 95, 96, 221 💬6. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||
| 7 | Leukocyte transendothelial migration 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Leukocyte transendothelial migration
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬7. Leukocyte transendothelial migration
|
||||||||||||||||||||||||||||||||||||
| 8 | Leukocyte transendothelial migration 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Efalizumab Efalizumab 💬Leukocyte transendothelial migration
| Efalizumab | 011 [9] 11, 13, 37, 46, 53, 61, 95, 96, 221 💬8. Leukocyte transendothelial migration
|
||||||||||||||||||||||||||||||||||||
| 9 | Malaria 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Malaria
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬9. Malaria
|
||||||||||||||||||||||||||||||||||||
| 10 | Malaria 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Efalizumab Efalizumab 💬Malaria
| Efalizumab | 011 [9] 11, 13, 37, 46, 53, 61, 95, 96, 221 💬10. Malaria
|
||||||||||||||||||||||||||||||||||||
| 11 | Natural killer cell mediated cytotoxicity 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Natural killer cell mediated cytotoxicity
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬11. Natural killer cell mediated cytotoxicity
|
||||||||||||||||||||||||||||||||||||
| 12 | Natural killer cell mediated cytotoxicity 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Efalizumab Efalizumab 💬Natural killer cell mediated cytotoxicity
| Efalizumab | 011 [9] 11, 13, 37, 46, 53, 61, 95, 96, 221 💬12. Natural killer cell mediated cytotoxicity
|
||||||||||||||||||||||||||||||||||||
| 13 | Neutrophil extracellular trap formation 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Neutrophil extracellular trap formation
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬13. Neutrophil extracellular trap formation
|
||||||||||||||||||||||||||||||||||||
| 14 | Neutrophil extracellular trap formation 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Efalizumab Efalizumab 💬Neutrophil extracellular trap formation
| Efalizumab | 011 [9] 11, 13, 37, 46, 53, 61, 95, 96, 221 💬14. Neutrophil extracellular trap formation
|
||||||||||||||||||||||||||||||||||||
| 15 | Rap1 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Rap1 signaling pathway
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬15. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||
| 16 | Rap1 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Efalizumab Efalizumab 💬Rap1 signaling pathway
| Efalizumab | 011 [9] 11, 13, 37, 46, 53, 61, 95, 96, 221 💬16. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||
| 17 | Regulation of actin cytoskeleton 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Regulation of actin cytoskeleton
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬17. Regulation of actin cytoskeleton
|
||||||||||||||||||||||||||||||||||||
| 18 | Regulation of actin cytoskeleton 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Efalizumab Efalizumab 💬Regulation of actin cytoskeleton
| Efalizumab | 011 [9] 11, 13, 37, 46, 53, 61, 95, 96, 221 💬18. Regulation of actin cytoskeleton
|
||||||||||||||||||||||||||||||||||||
| 19 | Rheumatoid arthritis 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Rheumatoid arthritis
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬19. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||
| 20 | Rheumatoid arthritis 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Efalizumab Efalizumab 💬Rheumatoid arthritis
| Efalizumab | 011 [9] 11, 13, 37, 46, 53, 61, 95, 96, 221 💬20. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||
| 21 | Staphylococcus aureus infection 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Staphylococcus aureus infection
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬21. Staphylococcus aureus infection
|
||||||||||||||||||||||||||||||||||||
| 22 | Staphylococcus aureus infection 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Efalizumab Efalizumab 💬Staphylococcus aureus infection
| Efalizumab | 011 [9] 11, 13, 37, 46, 53, 61, 95, 96, 221 💬22. Staphylococcus aureus infection
|
||||||||||||||||||||||||||||||||||||
| 23 | Viral myocarditis 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Viral myocarditis
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬23. Viral myocarditis
|
||||||||||||||||||||||||||||||||||||
| 24 | Viral myocarditis 💬 1 gene, 2 drugs (DrugBank) and 20 diseases |
ITGAL [1] ITGAL 💬Cell adhesion molecules
|
Efalizumab Efalizumab 💬Viral myocarditis
| Efalizumab | 011 [9] 11, 13, 37, 46, 53, 61, 95, 96, 221 💬24. Viral myocarditis
|
Cell adhesion molecules
1 gene, 2 drugs (DrugBank) and 20 diseases
Epstein-Barr virus infection
1 gene, 2 drugs (DrugBank) and 20 diseases
Human T-cell leukemia virus 1 infection
1 gene, 2 drugs (DrugBank) and 20 diseases
Leukocyte transendothelial migration
1 gene, 2 drugs (DrugBank) and 20 diseases
Malaria
1 gene, 2 drugs (DrugBank) and 20 diseases
Natural killer cell mediated cytotoxicity
1 gene, 2 drugs (DrugBank) and 20 diseases
Neutrophil extracellular trap formation
1 gene, 2 drugs (DrugBank) and 20 diseases
Rap1 signaling pathway
1 gene, 2 drugs (DrugBank) and 20 diseases
Regulation of actin cytoskeleton
1 gene, 2 drugs (DrugBank) and 20 diseases
Rheumatoid arthritis
1 gene, 2 drugs (DrugBank) and 20 diseases
Staphylococcus aureus infection
1 gene, 2 drugs (DrugBank) and 20 diseases
Viral myocarditis
1 gene, 2 drugs (DrugBank) and 20 diseases
